BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26469710)

  • 1. Prognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry.
    Chua SK; Lo HM; Chiu CZ; Shyu KG;
    Nephrology (Carlton); 2016 Jul; 21(7):583-91. PubMed ID: 26469710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of renal dysfunction on embolic stroke of undetermined source-Role beyond CHA
    Chua SK; Hsieh FI; Hu CJ; Wang IK; Lee JT; Yeh HL; Lin KY; Lai TC; Sun Y; Jeng JS; Lin CL; Lien LM; Hsu CY;
    Eur J Neurol; 2021 Apr; 28(4):1253-1264. PubMed ID: 33277744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHA
    Topaz G; Haisraely O; Shacham Y; Beery G; Shilo L; Kassem N; Pereg D; Kitay-Cohen Y
    Clin Cardiol; 2018 Apr; 41(4):539-543. PubMed ID: 29687656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke.
    Cha MJ; Lee HS; Kim YD; Nam HS; Heo JH
    Eur J Neurol; 2013 Sep; 20(9):1256-63. PubMed ID: 23560528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CHADS₂ and CHA₂DS₂-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry.
    Chua SK; Lo HM; Chiu CZ; Shyu KG
    PLoS One; 2014; 9(10):e111167. PubMed ID: 25343586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal dysfunction and the risk of postoperative atrial fibrillation after cardiac surgery: role beyond the CHA2DS2-VASc score.
    Chua SK; Shyu KG; Lu MJ; Hung HF; Cheng JJ; Chiu CZ; Lin CH; Chao HH; Lo HM
    Europace; 2015 Sep; 17(9):1363-70. PubMed ID: 25662985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
    Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
    Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
    Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of CHA
    Sun Y; Ren J; Wang W; Wang C; Li L; Yao H
    Clin Cardiol; 2023 Aug; 46(8):950-957. PubMed ID: 37430484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study about impact of renal dysfunction and morbidity and mortality on cardiovascular events after ischemic stroke.
    Penko M; Hojs Fabjan T; Bevc S; Kanič V; Hojs R
    Cardiol J; 2014; 21(2):163-9. PubMed ID: 23799556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA
    Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
    Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline CHA
    Díez-Villanueva P; Vera A; Ariza-Solé A; Formiga F; Martínez-Sellés M; Alegre O; Sanchís J; Marín F; Vidán M; López-Palop R; Abu-Assi E; Bueno H; Alfonso F;
    Int J Clin Pract; 2021 Jun; 75(6):e14082. PubMed ID: 33565683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CHA
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
    J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA₂DS₂-VASc score.
    Chao TF; Tsao HM; Ambrose K; Lin YJ; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Chung FP; Hanafy DA; Lin WY; Chen SA
    Heart Rhythm; 2012 Nov; 9(11):1755-60. PubMed ID: 22760084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.
    Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III.
    Baker WL; Coleman CI; White CM; Kluger J
    Pharmacotherapy; 2013 May; 33(5):489-95. PubMed ID: 23649811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHA
    Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA
    Mu X; Qiu M; Li Y; Li Z; Qi B; Jing Z; Jing Q
    Clin Cardiol; 2023 Jul; 46(7):810-817. PubMed ID: 37218400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHA
    Ye S; Qian M; Zhao B; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Lip GY; Thompson JL; Homma S;
    Eur J Heart Fail; 2016 Oct; 18(10):1261-1266. PubMed ID: 27444219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.